The early evidence Novo Nordisk announced in October that it had halted a trial of semaglutide in people with Type 2 diabetes and chronic kidney disease after an early analysis made clear the drug was effective, though the company has not yet released the data
They require lifestyle changes, close monitoring, and realistic expectations
The insulin resistance in PCOS might also occur independently of body weight, due to inherited post-receptor defects in insulin signalling that affects metabolism and mitotic pathways, not only in classic insulin target tissues, such as skeletal muscle, liver, and adipose tissue, but also in the non-classical target tissues, such as pituitary and ovary [12, 16]
www.jaoa.org/content/111/2_suppl_1/eS10.full
Yes, over-the-counter antacids, H2 blockers, and proton pump inhibitors are generally compatible with semaglutide